Summary

Overview
Europe's Medicinal Mushroom Market reached US$ 10.45 billion in 2024 and is expected to reach US$ 22.15 billion by 2032, growing with a CAGR of 9.85% during the forecast period 2025-2032.
Increasing consumer awareness about the health benefits of natural and functional foods is a major factor, as more people seek plant-based organic and wellness-oriented products. Medicinal mushrooms, known for their immune-boosting, anti-inflammatory and cognitive-enhancing properties, are increasingly incorporated into dietary supplements, teas and functional beverages.
For instance in April 2024, the Herbtender, an adaptogenic wellness brand, launched its wellness supplements in 600 Holland & Barrett stores across UK becoming a flagship functional mushroom brand for the retail chain. Crafted in UK by medical herbalists the Herbtender’s botanical blends include the Daily Defence tonic, featuring adaptogens like Astragalus, Reishi, Chaga and Cordyceps, designed to enhance resilience and restore vigor.
Dynamics
Driver 1 - Growing awareness of medicinal properties
The growing awareness of the medicinal properties of mushrooms is a major driver of the European medicinal mushroom market, as more consumers seek natural remedies for improving their health and well-being. Scientific research and traditional knowledge have highlighted the numerous benefits of mushrooms such as reishi, chaga, lion’s mane and cordyceps, which are known for their immune-boosting, anti-inflammatory and antioxidant properties.
As the wellness trend expands, people are increasingly looking for holistic and plant-based supplements to address issues like stress, cognitive decline, fatigue and immunity support. Medicinal mushrooms fit well within this trend, providing a natural alternative to synthetic supplements or pharmaceutical solutions. By promoting mushrooms as a vital component of a healthy diet, the organizations are taking the initiative to enhance consumer understanding of their medicinal properties, such as immune-boosting and anti-inflammatory effects.
For instance in July 2023, the European Mushroom Growers’ Association (GEPC) launched a EUR 5 million campaign titled “European mushroom, the hidden gem” to promote the benefits of European mushrooms among millennials. The initiative, co-funded by the EU, aims to boost sales by EUR 28 million over three years and will be rolled out in nine countries, including Belgium, France, Germany and Spain.
The campaign seeks to enhance consumer awareness of European mushrooms as a vital component of a healthy, balanced diet. This type of campaign, helps expand the market by encouraging more consumers to explore mushrooms as natural supplements. The increased visibility drives both demand and market growth for medicinal mushrooms in Europe.
Restraint: Competition from synthetic alternatives
The European medicinal mushroom market faces growing competition from synthetic alternatives, which is impacting its development. Synthetic options, particularly in pharmaceuticals, are often seen as more reliable, cost-effective and easily scalable, challenging the market for natural medicinal mushrooms, which can be limited by cultivation constraints and variability in active compounds.
Synthetic products also benefit from advanced research, regulation compliance and faster innovation cycles, providing consistent results that appeal to consumers seeking quick, reliable health solutions. In contrast, medicinal mushrooms rely on slower, more traditional cultivation methods, making them susceptible to market fluctuations, seasonal yields and varying efficacy based on growth conditions.
Additionally, synthetics often offer similar or superior therapeutic effects, such as immune modulation, antioxidant benefits and cognitive enhancement, which are key selling points for medicinal mushrooms. Consumer preference for convenience and predictable outcomes drives the shift towards synthetic supplements, which are typically available in standardized doses and forms, offering a more accessible health solution.
Segment Analysis
The Europe medicinal mushroom market is segmented based on product type, form, application, distribution channel and country.
Health conscious consumers and rising demand for organic, plant-based products like shiitake
According from large part to its well-known therapeutic advantages and high nutritional content, the shiitake mushroom category in the European medical mushroom industry is seeing rapid expansion. Due to their abundance in polysaccharides such as beta-glucans, which have been shown to support cardiovascular health and enhance immunological function, shiitake mushrooms are a common ingredient in functional meals, dietary supplements and wellness items.
Demand is booming throughout Europe as a result of consumers becoming more health-conscious and the growing popularity of natural, plant-based solutions. In remaining with growing consumer demand for sustainable organic and locally produced products, government polls and data from sources like Eurostat show that the organic food market in Europe, which includes mushrooms like shiitake, has been growing by about 7% yearly.
Supplements meant to enhance immune function, digestive health and general well-being frequently contain shiitake mushrooms, which are frequently found in health stores and online. They can also be found dried or powdered. Shiitake mushrooms can now be used in a wider range of culinary and nutraceutical uses because the European Food Safety Authority (EFSA) has designated them as a new food ingredient.
The increased demand for Shiitake in the functional foods category is indicated by its incorporation into numerous products, including soups, sauces and health beverages, notably in organic and vegan formulations. In home cooking as well as commercial food manufacturing, shiitake mushrooms are becoming more and more important as European consumers move toward holistic health practices. The European shiitake mushroom market is poised to grow further due to positive legislative support and health-related trends, as well as a consistent growth in demand.
Geographical Penetration
Rising awareness of health benefits in Germany
The demand for medicinal mushrooms in Europe has been on a consistent upward trend, fueled by rising awareness of their health benefits, especially in areas such as immune system support, cognitive health and stress management. Germany is one of the largest markets for medicinal mushrooms in Europe, driven by its strong health and wellness culture that favors natural and holistic treatments.
In 2023, the country witnessed a growth of about 6% in its dietary supplements sector, where medicinal mushrooms such as Reishi, Lion’s Mane and Cordyceps are increasingly being integrated. German consumers are drawn to these mushrooms due to their recognized health benefits. Reishi mushrooms, for example, are renowned for their potential to reduce inflammation and alleviate stress, while Lion’s Mane is widely sought after for its possible cognitive enhancement effects.
The aging population in Germany is contributing to the growing demand, as these mushrooms are often associated with improved mental health and anti-aging properties. A key factor driving the demand for medicinal mushrooms in Germany is the increasing consumer preference for natural supplements.
Competitive Landscape
The major Europe players in the market include Mycotrition GmbH, Tyroler Lucky Mushrooms, MycoTonics, Hirano Mushroom LLC, Shroomwell, Erbology, Nyishar, Isle of Wight Mushrooms Ltd, Bristol Fungarium and Mushlove Cornwall.
Sustainability Analysis
In the European medicinal mushroom market, companies are increasingly focused on sourcing mushrooms like Reishi, Shiitake and Lion’s Mane from sustainable and organic farms to meet consumer demand for eco-friendly products. The shift toward sustainability includes reducing the carbon footprint associated with the cultivation and transportation of these mushrooms. For instance, mushrooms that are cultivated using regenerative agricultural practices or in controlled environments have a lower environmental impact, aligning with consumer preferences for eco-friendly products.
Medicinal mushroom companies in Europe are transitioning towards sustainable sourcing practices. They are selecting ingredients that have minimal impact on biodiversity and promoting cultivation methods that are resource-efficient. This aligns with the increasing scrutiny from consumers on the sustainability credentials of products, especially in markets like Germany and France, where sustainability is a key purchasing factor for health and wellness products.
Medicinal mushroom companies are also incorporating sustainable packaging solutions, such as biodegradable or recyclable materials, to reduce plastic waste. As consumers become more environmentally conscious, particularly in Western European countries, they expect products to not only be sustainably sourced but also packaged in an eco-friendly manner. This shift is seen in medicinal mushroom-based supplements that often cater to the wellness-focused, eco-conscious demographic, driving companies to adopt more sustainable practices across the supply chain.
Consumer Behaviour Analysis
Nutritional Needs & Health Awareness: Medicinal mushrooms, like Reishi and Lion’s Mane, are increasingly recognized for their immune-boosting, stress-relief and cognitive-enhancing properties. Europe’s medicinal mushroom market is projected to grow at a faster pace during forecast years. Surveys indicate 43% of European consumers are familiar with medicinal mushrooms, with awareness highest in Germany, France and the UK. Immunity and mental health are the most cited benefits, with over 35% of consumers seeking these supplements for stress reduction and cognitive support.
Purchase Behavior & Preference: The European market is shifting toward organic, sustainably sourced products, with 68% of consumers preferring brands that offer clean labels and environmental consciousness. 45% of Europeans prioritize supplements focused on mental health and stress management, reflecting a growing interest in holistic and functional wellness. Brands offering adaptogenic mushrooms, like Cordyceps and Chaga, are gaining traction due to these preferences.
Early Stage Innovations
Personalized Mushroom Formulations have become a prominent trend in the supplement industry, with companies now offering custom blends tailored to specific health needs, such as immune support or stress relief. The personalized formulations are developed based on individual health assessments, meeting the growing consumer demand for targeted wellness solutions.
In addition, some brands are incorporating genetic testing to provide even more customized recommendations for mushroom-based supplements, addressing goals like cognitive enhancement and vitality. Enhanced Bioavailability Techniques are gaining attention, with innovations in extraction methods like supercritical CO2 extraction improving the bioavailability of active compounds found in mushrooms, such as Reishi and Lion’s Mane. This extraction process ensures that consumers receive maximum benefits from these powerful mushrooms.
Additionally, nano-encapsulation technologies are being used to enhance nutrient absorption by encapsulating mushroom extracts, allowing the body to more effectively utilize the beneficial compounds. Targeted Functional Ingredients are also emerging in the market, with products that combine medicinal mushrooms with additional functional ingredients like vitamins and minerals. Beverages infused with Chaga extracts, marketed for their antioxidant properties, are particularly appealing to health-conscious consumers.
Furthermore, the integration of probiotics with medicinal mushrooms is on the rise, creating synbiotic products that promote gut health, especially beneficial for vulnerable populations such as children and the elderly. Sustainability is another key focus, with brands emphasizing sustainably sourced medicinal mushrooms that support biodiversity. This trend, popular in regions like Germany and France, aligns with the values of environmentally conscious consumers. Additionally, companies are adopting eco-friendly packaging solutions, including biodegradable and recyclable materials, to appeal to consumers who are concerned about reducing plastic waste.
By Product Type
• Reishi
• Cordyceps
• Lion’s Mane
• Turkey Tail
• Shiitake
• Others
By Form
• Fresh
• Dried
• Others
By Application
• Dietary Supplements
o Immune Support
o Stress Relief and Adaptogens
o Cognitive Enhancement
o Energy and Stamina Boosters
o Others
• Pharmaceuticals
o Anticancer Agents
o Antimicrobial and Antiviral Treatments
o Anti-inflammatory Drugs
o Blood Sugar Regulation
o Others
• Functional Foods
o Nutrient-Enriched Foods
o Fortified Beverages
o Superfood Additives
o Others
• Cosmetics
o Skin Care Products
o Anti-Aging Formulations
o Moisturizers and Creams
o Others
• Personal Care Products
o Hair Care Products
o Bath and Body Care
o Oral Care Products
o Others
• Others
By Distribution Channel
• Supermarkets/Hypermarkets
• Online Retail
• Health Stores/Pharmacies
• Others
By Country
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
Key Developments
• In September 2022: Innomy, a Spanish business focused on mushroom-based meat substitutes, revealed it has secured EUR 1.3 million (US$ 1.26 million) in a Pre Series A fundraising round to expand, market and sell its products throughout Europe. According to Innomy, mycelium has a high nutritional value, low cholesterol and low saturated fat content, making it one of the most promising protein sources for the future.
Why Purchase the Report?
• To visualize the European medicinal mushroom market segmentation based on product type, form, application, distribution channel and country, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the medicinal mushroom market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The Europe medicinal mushroom market report would provide approximately 45 tables, 39 figures and 192 pages.
Target Audience 2025
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet By Product Type
3.2. Snippet By Form
3.3. Snippet By Application
3.4. Snippet By Distribution Channel
3.5. Snippet By Country
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing Awareness of Medicinal Properties
4.1.2. Restraints
4.1.2.1. Competition from Synthetic Alternatives
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Reishi*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Cordyceps
6.4. Lion’s Mane
6.5. Turkey Tail
6.6. Shiitake
6.7. Others
7. By Form
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
7.1.2. Market Attractiveness Index, By Form
7.2. Fresh*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Dried
7.4. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dietary Supplements
8.1.2. Market Attractiveness Index, By Dietary Supplements
8.2. Pharmaceuticals*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Immune Support
8.2.4. Stress Relief and Adaptogens
8.2.5. Cognitive Enhancement
8.2.6. Energy and Stamina Boosters
8.2.7. Others
8.3. Pharmaceuticals
8.3.1. Anticancer Agents
8.3.2. Antimicrobial and Antiviral Treatments
8.3.3. Anti-inflammatory Drugs
8.3.4. Blood Sugar Regulation
8.3.5. Others
8.4. Functional Foods
8.4.1. Nutrient-Enriched Foods
8.4.2. Fortified Beverages
8.4.3. Superfood Additives
8.4.4. Others
8.5. Cosmetics
8.5.1. Skin Care Products
8.5.2. Anti-Aging Formulations
8.5.3. Moisturizers and Creams
8.5.4. Others
8.6. Personal Care Products
8.6.1. Hair Care Products
8.6.2. Bath and Body Care
8.6.3. Oral Care Products
8.6.4. Others
8.7. Others
9. By Distribution Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. B2B*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. B2C
10. Country
10.1. Europe
10.1.1. Introduction
10.1.2. Key Country-Specific Dynamics
10.1.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.1.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.1.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.1.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.1.7.1. Germany
10.1.7.2. UK
10.1.7.3. France
10.1.7.4. Spain
10.1.7.5. Rest of Europe
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Mycotrition GmbH*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Tyroler Lucky Mushrooms
12.3. MycoTonics
12.4. Hirano Mushroom LLC
12.5. Shroomwell
12.6. Erbology
12.7. Nyishar
12.8. Isle of Wight Mushrooms Ltd
12.9. Bristol Fungarium
12.10. Mushlove Cornwall
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us